Balance Sheet

v3.26.1

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 165,922	$ 216,890
Accounts receivable, net	33,415	25,498
Inventory	40,462	40,495
Prepaid expenses and other current assets	11,937	13,368
Total current assets	251,736	296,251
Property and equipment, net	146,930	151,479
Goodwill	129,429	129,429
Intangible assets, net	144,887	151,543
Other assets	40,235	41,875
Total assets	713,217	770,577
Current liabilities:
Accounts payable	8,535	2,910
Accrued expenses and other current liabilities	28,647	36,567
Current portion of long-term debt	5,440	5,440
Total current liabilities	42,622	44,917
Long-term debt, less current portion	235,571	286,331
Finance lease liabilities, less current portion	29,869	30,141
Other long-term liabilities	36,072	36,477
Total liabilities	344,134	397,866
Commitments and contingencies (Note 6)
Stockholders’ equity:
Additional paid-in capital	202,131	199,177
Retained earnings	6,385	10,118
Accumulated other comprehensive income	466	524
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	211,564	212,379
Non-controlling interest	157,519	160,332
Total stockholders’ equity	369,083	372,711
Total liabilities and stockholders’ equity	713,217	770,577
Class A Common Stock
Stockholders’ equity:
Common stock	1,475	1,453
Class B Common Stock
Stockholders’ equity:
Common stock	$ 1,107	$ 1,107

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source